Politicians, from the president to representatives in Congress, have pledged to protect Medicare. Advocates should pressure them to fulfill that pledge.
Politicians, from the president to representatives in Congress, have pledged to protect Medicare. Advocates should pressure them to fulfill that pledge.

Threats to Medicare continue in 2019

By Bob Blancato

Medicare faces numerous threats in 2019. It’s time for lawmakers and healthcare advocates to attack these challenges head on.

One threat stems from the Trump administration, which has suggested weakening the so-called protected classes provision in Medicare “Part D.”

Medicare’s Part D drug benefit has enabled seniors to purchase subsidized prescription coverage from private insurers. Part D regulations require every plan to cover all medications in six protected classes of therapies, including anticonvulsants, antidepressants, antineoplastics, antipsychotics, antiretrovirals, and immunosuppressants. This protection ensures that older adults who battle cancer, HIV/AIDS, depression, and other serious diseases have a full range of treatment options.

The administration’s proposal would allow Medicare Part D plans to stop covering some of the most popular and needed medications in these classes. Key medical and patient advocacy groups have indicated that the proposal should be withdrawn.

Another threat lurking for beneficiaries relates to the importation of prescription drugs. Some politicians argue that certain drugs can be obtained cheaper if imported from other countries, assuming that price is the only factor that should motivate consumers.

However, consumers should also be concerned with the safety of imported drugs. Is the drug developed in a safe manner? Is it counterfeit? In other words, could it be a threat to the health of a person who uses the imported drug?

It is essential that the most stringent safety requirements be developed before there is any discussion of importation. All drugs that might be imported must pass this rigorous safety test.

In the highly-charged atmosphere around drug prices, importation will be a front and center issue. Different bills permitting everything from unlimited importation to very limited importation will be presented in this session of Congress. Sens. Chuck Grassley and Amy Klobuchar already introduced one importation bill, the “Safe and Affordable Drugs from Canada Act of 2019.” However, the rallying cry from advocates must be safety first.

Another concern relates to Medicare Part D’s Low-Income Subsidy, or LIS, program, which enables enrollees to obtain heavily discounted prescriptions. Some influential government advisors have proposed raising these enrollees’ co-pays for certain necessary prescriptions. The program is a lifeline for low-income, older adults needing prescription drugs. All efforts to squeeze this vulnerable group of older Americans must be resisted.

Further, we need to do a better job of raising awareness about the LIS program to those older Americans from minority communities who are underutilizing this important benefit.

Medicare has been an unqualified success. Politicians, from the president to representatives in Congress, have pledged to protect Medicare. Advocates should pressure them to fulfill that pledge.

Bob Blancato is executive director of the National Association of Nutrition and Aging Services Programs.

The viewpoints expressed above are those of the author and do not necessarily reflect those of The Independent.

How to submit an article, guest opinion piece, or letter to the editor to The Independent

Do you have something to say? Want your voice to be heard by thousands of readers? Send The Independent your letter to the editor or guest opinion piece. All submissions will be considered for publication by our editorial staff. If your letter or editorial is accepted, it will run on suindependent.com, and we’ll promote it through all of our social media channels. We may even decide to include it in our monthly print edition. Just follow our simple submission guidelines and make your voice heard:

—Submissions should be between 300 and 1,500 words.

—Submissions must be sent to editor@infowest.com as a .doc, .docx, .txt, or .rtf file.

—The subject line of the email containing your submission should read “Letter to the editor.”

—Attach your name to both the email and the document file (we don’t run anonymous letters).

—If you have a photo or image you’d like us to use and it’s in .jpg format, at least 1200 X 754 pixels large, and your intellectual property (you own the copyright), feel free to attach it as well, though we reserve the right to choose a different image.

—If you are on Twitter and would like a shout-out when your piece or letter is published, include that in your correspondence and we’ll give you a mention at the time of publication.

Articles related to “Threats to Medicare continue in 2019”

Under Medicare for All, government may micromanage your pizza order

The truth about Medicare for All

What you don’t know about Medicare for All can hurt you

Click This Ad

LEAVE A REPLY

Please enter your comment!
Please enter your name here